Edition:
United States

AB Science SA (ABS.PA)

ABS.PA on Paris Stock Exchange

4.91EUR
11:35am EDT
Change (% chg)

€0.06 (+1.24%)
Prev Close
€4.85
Open
€4.82
Day's High
€5.14
Day's Low
€4.77
Volume
521,766
Avg. Vol
145,456
52-wk High
€16.85
52-wk Low
€4.76

Select another date:

Thu, Apr 19 2018

BRIEF-AB Science Announces Negative Opinion From CHMP

* REG-AB SCIENCE ANNOUNCES THAT THE CHMP HAS ADOPTED A NEGATIVE OPINION FOR THE MARKETING AUTHORIZATION OF MASITINIB IN AMYOTROPHIC LATERAL SCLEROSIS

BRIEF-Ab Science Says IDMC Recommends Continuation Of masitinib Phase 3 Study With No Requirement To Increase Sample Size

* REG-AB SCIENCE ANNOUNCES THAT BASED ON INTERIM ANALYSIS, IDMC RECOMMENDED THE CONTINUATION OF THE MASITINIB PHASE 3 STUDY IN PROGRESSIVE MULTIPLE SCLEROSIS WITH NO REQUIREMENT TO INCREASE THE SAMPLE SIZE

BRIEF-AB Science announces publication of preclinical data showing that masitinb is capable of counteracting resistance to oncology treatments

* REG-AB SCIENCE ANNOUNCES THE PUBLICATION OF PRECLINICAL DATA SHOWING THAT MASITINB IS CAPABLE OF COUNTERACTING RESISTANCE TO ONCOLOGY TREATMENTS

Select another date: